• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
The 2022 Year in FDA 510(k) Approvals

The 2022 Year in FDA 510(k) Approvals

by Glenn S. Demby | Feb 1, 2023 | News, Open Content

Roche and Abbott received the most approvals for new lab tests last year.

Early in Pandemic, HIV Testing Dropped Sharply, but Quickly Rebounded

by Glenn S. Demby | Jan 26, 2023 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Testing Trends-dtet

A recent CDC report concludes that disruptions to HIV testing due to the COVID-19 pandemic compromised America’s ability to prevent the disease.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here

Recent Discovery Could Lead to a Better Lyme Disease Test

by Glenn S. Demby | Dec 21, 2022 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Special Focus-dtet

Researchers have identified 35 genes found in high expression in people with long-term Lyme disease, which could lead to earlier detection.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
A Brief Look at the COVID-19 Saliva Testing Global Market

A Brief Look at the COVID-19 Saliva Testing Global Market

by Glenn S. Demby | Dec 1, 2022 | Essential, Industry Buzz-lir, Laboratory Industry Report

The recent FDA approval of an OTC test shows that COVID-19 saliva testing may be poised for bigger and better things in the years ahead.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
SARS-CoV-2 Saliva Testing Gains Traction

SARS-CoV-2 Saliva Testing Gains Traction

by Glenn S. Demby | Nov 22, 2022 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Top of the News-dtet

Saliva testing for the virus that causes COVID-19 is gaining acceptance in both the scientific community and US market.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com